Live Breaking News & Updates on Fluoguideas Stock Exchange

Stay updated with breaking news from Fluoguideas stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fluoguide Q4 2022 - Slightly shifted timelines but equity story remains unchanged

Redeye comments on Fluoguide’s Q4 2022 report as we enter a catalyst-rich 2023e for the company. Fluoguide recently announced a slight delay in phase IIb HGG top-line data, though we judge that. | March 1, 2023 ....

Research Powered Investment Banking , Life Science , Powered Investment , Fluoguideas Stock Exchange , Press Release , Udge Fluo Dk0061123312 ,

FluoGuide releases positive interim result of FG001-CT002, a phase IIa trial evaluating FG001 in patients with non-small cell lung cancer (NSCLC) undergoing surgery

Copenhagen, Denmark, 6 November 2022 - FluoGuide A/S is pleased to announce that FG001 lights up in 5 out of 7 patients in an interim evaluation in the ongoing phase IIa trial in non-small cell lung. | November 6, 2022 ....

Fluoguideas Fluoguide , Morten Albrechtsen , European Union Horizon , University Hospital , National Lung Screening Trial Research Team , Department Of Cardiothoracic Surgery , Cardiothoracic Surgery , Abuse Regulation , Nasdaq First North Sweden , Cancer Statistics , Mortality Worldwide , National Lung Screening Trial Research , Reduced Lung Cancer Mortality , Low Dose Computed Tomographic , Fluoguideas Stock Exchange , Press Release , Ell Fluo Dk0061123312 ,